We are thrilled to share a significant breakthrough. The IRB has officially granted approval for our Percepta human trial. This initiative marks a monumental milestone as the first instance in the world of a decentralized, randomized controlled trial being crowd-funded through IP tokens. The study is designed to be double-blinded and will take place over a duration of 6 months. We want to extend our sincere gratitude to every individual who has backed this project. Please continue to check for updates via @Neuron_Percepta